Lv5
1368 积分 2021-10-03 加入
CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity
19天前
已完结
CRMP5 antibodies in patients with small-cell lung cancer or thymoma
24天前
已完结
CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis
24天前
已完结
Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases
24天前
已完结
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies
1个月前
已完结
Anti-CV2/Collapsin Response Mediator Protein 5 (CRMP5) Paraneoplastic Encephalitis Induced by Small Cell Lung Cancer
1个月前
已完结
Anti-CV2 Autoantibodies and Paraneoplastic Neurological Syndromes
1个月前
已完结
Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review
2个月前
已完结
Successful sequential treatment with ofatumumab followed by efgartigimod for refractory autoimmune encephalitis with dual anti-NMDAR and anti-GFAP antibody positivity: first case report
2个月前
已完结
Efgartigimod as a Fast‐Acting Add‐On Therapy in Antibody–Mediated Autoimmune Encephalitis
2个月前
已完结
皖公网安备34019202002308
